These results are in agreement with Wu et al. [67], who noticed that CARV treatment inhibited MMP9 expression in atherosclerotic rat model and Raimundo Fernandes et al. [68], who demonstrated a reduction in the formation of MMP-9 with carvedilol treatment in an experimental model of periodontal disease. Here, MMP9 is linked to periodontal disorder.